Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly

1 Jan 2017

Abstract excerpt

Taken together, we generated four long-term maintenance BCSC derived from either clinical specimens or cell lines, which would be greatly beneficial to the research progress in breast cancer patients. We further developed the non-viral TV-miR-34a plasmid, which has a great potential to be applied as a clinical application for breast cancer therapy.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Mesenchymal stem cell research
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29187905
DOI: 10.7150/thno.20771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 DirectlyPMID 29187905Read ↗

MiR-422a weakened breast cancer stem cells properties by targeting PLP2Semantic proximity Read ↗

Targeting of miR34a–NOTCH1 Axis Reduced Breast Cancer Stemness and ChemoresistanceSemantic proximity Read ↗

Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivoSemantic proximity Read ↗

Combined transcriptional, translational and cell surface targeted gene therapy of HER2-positive breast cancer stem cells in three-dimentional cell cultureSemantic proximity Read ↗

Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapySemantic proximity Read ↗

The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy.Semantic proximity Read ↗

MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating CellsSemantic proximity Read ↗

Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cellsSemantic proximity Read ↗

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancerSemantic proximity Read ↗

Deregulation of miR-34a, miR-221 and miR-222 after HT29 cells treatment with Silibinin encapsulated in polymersomes as an anti-cancer stem cell agentSemantic proximity Read ↗

Gene expression profiles of some prognostic markers in a human breast cell line (MCF7) exposed to Curcumin nanoparticles and nanocapsulesSemantic proximity Read ↗

Lentiviral Engineered cells for production of miR34a loaded exosomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.